Injury to atherosclerotic arteries induces the expression of growth regulatory genes that stimulate cellular proliferation and intimal formation. Intimal expansion has been reduced in vivo in nonatherosclerotic balloon-injured arteries by transfer of genes that inhibit cell proliferation. It is not known, however, whether vascular cell proliferation can be inhibited after injury in more extensively diseased atherosclerotic arteries. Accordingly, the purpose of this study was to investigate whether expression of recombinant genes in atherosclerotic arteries after balloon injury could inhibit intimal cell proliferation. To test this hypothesis, we examined the response to balloon injury in atherosclerotic rabbit arteries after gene transfer of herpesvirus thymidine kinase gene (tk) and administration of ganciclovir. Smooth muscle cells from hyperlipidemic rabbit arteries infected with adenoviral vectors encoding tk were sensitive to ganciclovir, and bystander killing was observed in vitro. In atherosclerotic arteries, a human placental alkaline phosphatase reporter gene was expressed in intimal and medial smooth muscle cells and macrophages, identifying these cells as targets for gene transfer. Expression of tk in balloon-injured hyperlipidemic rabbit arteries followed by ganciclovir treatment resulted in a 64% reduction in intimal cell proliferation 7 d after gene transfer (P = 0.004), and a 35-49% reduction in internal area 21 d after gene transfer, compared with five different control groups (P < 0.05). Replication of smooth muscle cells and macrophages was inhibited by tk expression and ganciclovir treatment. These findings indicate that transfer of a gene that inhibits cellular proliferation limits the intimal area in balloon-injured atherosclerotic arteries. Molecular approaches to the inhibition of cell proliferation in atherosclerotic arteries constitute a possible treatment for vascular proliferative diseases.
R D Simari, H San, M Rekhter, T Ohno, D Gordon, G J Nabel, E G Nabel
Title and authors | Publication | Year |
---|---|---|
Gene transfer to the vascular system: Novel translational perspectives for vascular diseases
A Remes, DI Basha, N Frey, AH Wagner, OJ Müller |
Biochemical Pharmacology | 2020 |
A Metabolic Intravascular Platform to Study FDG Uptake in Vascular Injury
F Franchi, M Olthoff, J Krier, C Noble, M Al-Hijji, V Ramaswamy, T Witt, M Burke, M Benscoter, A Lerman, GS Sandhu, M Rodriguez-Porcel |
Cardiovascular Engineering and Technology | 2020 |
Forging the Fate of Cellular Therapies for Cardiovascular Disease
RD Simari |
Circulation research | 2017 |
Presentation of Kober Medal to Elizabeth G. Nabel
Eugene Braunwald |
Journal of Clinical Investigation | 2014 |
Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis
RX Yin, DZ Yang, JZ Wu |
Theranostics | 2014 |
Nanotechnology-Based Gene-Eluting Stents
D Goh, A Tan, Y Farhatnia, J Rajadas, MS Alavijeh, AM Seifalian |
Molecular Pharmaceutics | 2013 |
Perivascular administration of drugs and genes as a means of reducing vein graft failure
D Wiedemann, A Kocher, N Bonaros, S Semsroth, G Laufer, M Grimm, T Schachner |
Current Opinion in Pharmacology | 2012 |
Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development
S Pan, TA White, TA Witt, A Chiriac, CS Mueske, RD Simari |
Circulation research | 2009 |
Nanoparticulate carriers for the treatment of coronary restenosis
L Brito, M Amiji |
International Journal of Nanomedicine | 2007 |
Endothelial dysfunction and restenosis following percutaneous coronary intervention
P Thanyasiri, K Kathir, DS Celermajer, MR Adams |
International Journal of Cardiology | 2007 |
Gene therapy for restenosis: Biological solution to a biological problem
R Kishore, DW Losordo |
Journal of Molecular and Cellular Cardiology | 2007 |
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes |
2007 | |
Essentials of Restenosis
HJ Duckers, EG Nabel, PW Serruys |
2007 | |
Cardiovascular gene delivery: The good road is awaiting☆
LP Brewster, EM Brey, HP Greisler |
Advanced Drug Delivery Reviews | 2006 |
Localized vessel expression of lipoprotein lipase in rabbits leads to rapid lipid deposition in the balloon-injured arterial wall
X Wu, J Wang, J Fan, M Chen, L Chen, W Huang, G Liu |
Atherosclerosis | 2006 |
VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection
PJ Sheridan, A Lawrie, DC Crossman, CM Holt, CM Newman |
The Journal of Gene Medicine | 2005 |
Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone
K Katsube, AT Bishop, RD Simari, S Ylä-Herttuala, PF Friedrich |
Journal of Orthopaedic Research | 2005 |
Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end?
SV Pislaru, RD Simari |
Nature Clinical Practice Cardiovascular Medicine | 2005 |
Catheter-mediated delivery of adenoviral vectors expressing β-adrenergic receptor kinase C-terminus inhibits intimal hyperplasia and luminal stenosis in rabbit iliac arteries
Z Luo, M Palasis, M Yamakawa, LX Liu, KA Vincent, L Trudell, GA Akita, WJ Koch, SH Cheng, RJ Gregory, C Jiang |
The Journal of Gene Medicine | 2004 |
Applied gene therapy in preclinical models of vascular injury
SP Janssens |
Current Atherosclerosis Reports | 2003 |
Preventing saphenous vein graft failure: does gene therapy have a role?
EF Akowuah, PJ Sheridan, GJ Cooper, C Newman |
The Annals of Thoracic Surgery | 2003 |
Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent
A Takahashi, M Palmer-Opolski, RC Smith, K Walsh |
Gene Therapy | 2003 |
Nonviral gene transfer strategies for the vasculature
Jennifer L Young, David A Dean |
Microcirculation (New York, N.Y. : 1994) | 2002 |
Nonviral Gene Transfer Strategies for the Vasculature
JL Young, DA Dean |
Microcirculation | 2002 |
Gene therapy in vascular surgery comes of age
Y Yonemitsu, K Komori, K Sueishi, K Sugimachi |
Surgery | 2002 |
Blockade of Human Immunodeficiency Virus Type 1 Expression by Caveolin-1
M Llano, T Kelly, M Vanegas, M Peretz, TE Peterson, RD Simari, EM Poeschla |
Journal of virology | 2002 |
Gene Therapy for Restenosis: Current Status
J Rutanen, J Markkanen, S Yl-Herttuala |
Drugs | 2002 |
Interventionelle Gefäßtherapie
C Vallbracht, FJ Roth, AL Strauss |
2002 | |
Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
H Ju, S Nerurkar, CF Sauermelch, AR Olzinski, R Mirabile, D Zimmerman, JC Lee, J Adams, J Sisko, M Berova, RN Willette |
The Journal of pharmacology and experimental therapeutics | 2002 |
Clinical Trials in Vascular Gene Therapy
RD Simari, T O'Brien |
Archives of pathology & laboratory medicine | 2002 |
Current Protocols in Human Genetics
RG Cotton, M Grompe |
Current Protocols in Human Genetics | 2001 |
Local gene delivery to the vessel wall
RC Smith, K Walsh |
Acta Physiologica Scandinavica | 2001 |
Gene Therapy in Cardiovascular Disease
SC Francis, MJ Katovich, CH Gelband, MK Raizada |
American Journal of PharmacoGenomics | 2001 |
Enhancement of Fas Ligand-Induced Inhibition of Neointimal Formation in Rabbit Femoral and Iliac Arteries by Coexpression of p35
Z Luo, T Garron, M Palasis, H Lu, AJ Belanger, A Scaria, KA Vincent, T Date, GY Akita, SH Cheng, J Barry, RJ Gregory, C Jiang |
Human Gene Therapy | 2001 |
Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG)
RJ Lederman, RR Raylman, SJ Fisher, PV Kison, H San, EG Nabel, RL Wahl |
Nuclear Medicine Communications | 2001 |
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu |
Heart Physiology and Pathophysiology | 2001 |
Role for tissue factor pathway in murine model of vascular remodeling
R Singh, S Pan, CS Mueske, T Witt, LS Kleppe, TE Peterson, A Slobodova, JY Chang, NM Caplice, RD Simari |
Circulation research | 2001 |
Coexpression of Guanylate Kinase with Thymidine Kinase Enhances Prodrug Cell Killing in Vitro and Suppresses Vascular Smooth Muscle Cell Proliferation in Vivo
LM Akyürek, S Nallamshetty, K Aoki, H San, ZY Yang, GJ Nabel, EG Nabel |
Molecular Therapy | 2001 |
Atherogenic Lipids and Endothelial Dysfunction: Mechanisms in the Genesis of Ischemic Syndromes
MR Adams, S Kinlay, GJ Blake, JL Orford, P Ganz, AP Selwyn |
Annual Review of Medicine | 2000 |
Cardiovascular gene therapy
S Ylä-Herttuala, JF Martin |
The Lancet | 2000 |
Analysis of Adenoviral Transport Mechanisms in the Vessel Wall and Optimization of Gene Transfer Using Local Delivery Catheters
M Palasis, Z Luo, JJ Barry, K Walsh |
Human Gene Therapy | 2000 |
Percutaneous Gene Therapy Using Recombinant Adenoviruses Encoding Human Herpes Simplex Virus Thymidine Kinase, Human PAI-1, and Human NOS3 in Balloon-Injured Porcine Coronary Arteries
O Varenne, P Sinnaeve, H Gillijns, B Iung, V Laurysens, K Meurrens, B Bout, D Valerio, D Colin, SP Janssens, RD Gerard |
Human Gene Therapy | 2000 |
PROSPECTS FOR GENETIC THERAPY OF CARDIOVASCULAR DISEASE
HJ Duckers, EG Nabel |
Medical Clinics of North America | 2000 |
Gene Therapy for Atherosclerotic Cardiovascular Disease: A Time for Optimism and Caution
T O'brien, RD Simari |
Mayo Clinic Proceedings | 2000 |
Gene delivery from a DNA controlled-release stent in porcine coronary arteries
BD Klugherz, PL Jones, X Cui, W Chen, NF Meneveau, S DeFelice, J Connolly, RL Wilensky, RJ Levy |
Nature Biotechnology | 2000 |
Biocompatibility of Cardiovascular Gene Delivery Catheters with Adenovirus Vectors: An Important Determinant of the Efficiency of Cardiovascular Gene Transfer
D Marshall |
Molecular Therapy | 2000 |
Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries
L Maillard, EV Belle, FO Tio, A Rivard, M Kearney, D Branellec, PG Steg, JM Isner, K Walsh |
Gene Therapy | 2000 |
Gene Therapy for Restenosis
MR Kibbe, TR Billiar, E Tzeng |
Circulation research | 2000 |
Atherosclerosis Progression in LDL Receptor–Deficient and Apolipoprotein E–Deficient Mice Is Independent of Genetic Alterations in Plasminogen Activator Inhibitor-1
H Sjöland, DT Eitzman, D Gordon, R Westrick, EG Nabel, D Ginsburg |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Molecular biology and gene transfer in atherosclerosis in the stenting era
NM Caplice, RD Simari, DR Holmes |
Acute Cardiac Care | 1999 |
Percutaneous Adenoviral Gene Transfer into Porcine Coronary Arteries: Is Catheter-Based Gene Delivery Adapted to Coronary Circulation?
O Varenne, RD Gerard, P Sinnaeve, H Gillijns, D Collen, S Janssens |
Human Gene Therapy | 1999 |
Early Cell Loss after Angioplasty Results in a Disproportionate Decrease in Percutaneous Gene Transfer to the Vessel Wall
A Rivard, Z Luo, H Perlman, JE Fabre, T Nguyen, L Maillard, K Walsh |
Human Gene Therapy | 1999 |
Pulmonary Vascular Gene Transfer: Prospects for Successful Therapy of Pulmonary Hypertension
B Fouty, DM Rodman |
American journal of respiratory cell and molecular biology | 1999 |
Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis
H Perlman, Z Luo, K Krasinski, AL Roux, A Mahfoudi, RC Smith, D Branellec, K Walsh |
Gene Therapy | 1999 |
Enhanced Recovery of Injury-Caused Downregulation of Paxillin Protein by eNOS Gene Expression in Rat Carotid Artery: Mechanism of NO Inhibition of Intimal Hyperplasia?
S Fang, RV Sharma, RC Bhalla |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Vascular Gene Transfer: From Bench to Bedside
IJ Kullo, RD Simari, RS Schwartz |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Cardiovascular Specific Gene Expression
PA Doevendans, RS Reneman, M van Bilsen |
1999 | |
Effects of Poloxamer 407 on Transfection Time and Percutaneous Adenovirus-Mediated Gene Transfer in Native and Stented Vessels
E Belle, L Maillard, A Rivard, JE Fabre, T Couffinhal, M Kearney, D Branellec, LJ Feldman, K Walsh, JM Isner |
Human Gene Therapy | 1998 |
Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine
G Mozes, IJ Kullo, TG Mohacsi, DG Cable, DJ Spector, TB Crotty, P Gloviczki, ZS Katusic, T O'Brien |
Atherosclerosis | 1998 |
Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous Vein
SJ George, JL Johnson, GD Angelini, AC Newby, AH Baker |
Human Gene Therapy | 1998 |
NORMAL AND ABNORMAL CONSEQUENCES OF APOPTOSIS IN THE HUMAN HEART
TN James |
Annual Review of Physiology | 1998 |
Requirements for enhanced transgene expression by untranslated sequences from the human cytomegalovirus immediate-early gene
RD Simari, ZY Yang, X Ling, D Stephan, ND Perkins, GJ Nabel, EG Nabel |
Molecular Medicine | 1998 |
Gene Transfer Into Normal and Atherosclerotic Human Blood Vessels
MD Rekhter, RD Simari, CW Work, GJ Nabel, EG Nabel, D Gordon |
Circulation research | 1998 |
Local Adenovirus-Mediated Transfer of Human Endothelial Nitric Oxide Synthase Reduces Luminal Narrowing After Coronary Angioplasty in Pigs
O Varenne, S Pislaru, H Gillijns, NV Pelt, RD Gerard, P Zoldhelyi, FV de Werf, D Collen, SP Janssens |
Circulation | 1998 |
Gene Therapy for Restenosis: Are We Ready?
MB DeYoung, DA Dichek |
Circulation research | 1998 |
Gene Therapy for Restenosis: Getting Nearer the Heart of the Matter
S Baek, KL March |
Circulation research | 1998 |
Graft Permeabilization Facilitates Gene Therapy of Transplant Arteriosclerosis in a Rabbit Model
MD Rekhter, N Shah, RD Simari, C Work, JS Kim, GJ Nabel, EG Nabel, D Gordon |
Circulation | 1998 |
Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo
S Kim, H Lin, E Barr, L Chu, JM Leiden, MS Parmacek |
Journal of Clinical Investigation | 1997 |
Gene and other biological therapies for vascular diseases
D Stephan, EG Nabel |
Fundamental & Clinical Pharmacology | 1997 |
In Vivo Gene Transfer: A Biological Tool
EG Nabel, R Simari, Z Yang, H San, GJ Nabel |
Annals of the New York Academy of Sciences | 1997 |
Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease
AP Selwyn, S Kinlay, M Creager, P Libby, P Ganz |
The American Journal of Cardiology | 1997 |
Antithrombotic gene therapy
RD Gerard |
Fibrinolysis and Proteolysis | 1997 |
Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis
RD Gerard, D Collen |
Cardiovascular Research | 1997 |
Problem of Angioplasty in Diabetics
SG Ellis, CR Narins |
Circulation | 1997 |
Reduction of Restenosis After Angioplasty in an Atheromatous Rabbit Model by Suicide Gene Therapy
PG Steg, O Tahlil, N Aubailly, JM Caillaud, JF Dedieu, K Berthelot, AL Roux, L Feldman, M Perricaudet, P Denèfle, D Branellec |
Circulation | 1997 |
Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Accumulation by Adenovirus-Mediated Gene Transfer of Cytosine Deaminase
RL Harrell, MA Rajanayagam, AM Doanes, RJ Guzman, EA Hirschowitz, RG Crystal, SE Epstein, T Finkel |
Circulation | 1997 |
Arterial Remodeling: A Critical Factor in Restenosis
A Lafont, EJ Topol |
1997 | |
A New Cationic Liposome DNA Complex Enhances the Efficiency of Arterial Gene TransferIn Vivo
DJ Stephan, ZY Yang, H San, RD Simari, CJ Wheeler, PL Felgner, D Gordon, GJ Nabel, EG Nabel |
Human Gene Therapy | 1996 |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |